GLP-1 Shift: Why 71% Want Oral Pills
Survey shows 71% prefer daily oral pills over weekly injections. Novo executives predict oral drugs could capture half the global market. Injectables still hold 93% share, but oral semaglutide prescriptions are rising.
Choose the option closest to your current judgment.
Known and confirmed
- Survey shows 71% prefer daily oral pills over weekly injections.
- Novo executives predict oral drugs could capture half the global market.
- Injectables still hold 93% share, but oral semaglutide prescriptions are rising.
Unknown or unverified
- 长期口服药的依从性与实际减重效果的对比数据尚不充分。
- 不同品牌口服药的具体副作用差异尚未完全明确。
- 保险覆盖范围可能影响患者的最终选择。
Original sources
1 sourcesYour choice
Take a stand alongside AI
If oral GLP-1 drugs offer equal efficacy and fewer side effects than injections, would you switch from injection to oral?
Comparison standard: Choose the option closest to your current judgment.